Biological material pre-fixation treatment |
| OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ... |
|
Method for bonding or fusion of biological tissue and material |
| Biological materials are joined, repaired or fused by heating the material in proximity to a ... |
|
Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome |
| OF THE INVENTION The present invention is directed to the determination that SVAS and Williams ... |
|
Biological material pre-fixation treatment |
| OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ... |
|
Matrix substrate for a viable body tissue-derived prosthesis and method for making the same |
| OF THE INVENTION The present invention covers a process that thoroughly removes intact cells from ... |
|
Barrier webs having bioactive surfaces |
| What is claimed is: 1. A bioactive substrate comprising: a support; and a bioactive surface thereon,... |
|
Biopolymer foams for use in tissue repair and reconstruction |
| OF THE INVENTION The present invention features biopolymer foams, composite biopolymer foams, ... |
|
Periodate oxidative method for attachment of biomolecules to medical device surfaces |
| OF THE INVENTION As used in the specification and claims hereof, the following terms have the ... |
|
Self-aligning peptides modeled on human elastin and other fibrous proteins |
| OF PREFERRED EMBODIMENTS The present invention is directed to unique polypeptides modeled on human ... |
|
Prosthetic devices including elastin or elastin-based materials |
| It is a specific object of the invention to provide an elastin-based prosthetic device suitable for ... |
|
|
Expressed sequence tags and encoded human proteins
| Details |
Inventors: Edwards, Jean-Baptiste Dumas Milne; Duclert, Aymeric; Giordano, Jean-Yves;
Assignee: Genset S.A. (FR)
Primary Examiner: Martinell; James
Assistant Examiner:
Attorney, Agent or Firm: Saliwanchik, Lloyd & Saliwanchik
The sequences of 5' ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5' ESTs may be to obtain cDNAs and genomic DNAs corresponding to the 5' ESTs. The 5' ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5' ESTs. The 5' ESTs may also be used to design expression vectors and secretion vectors. |
|
DETAILED DESCRIPTION The present invention relates to purified, isolated, or enriched 5' ESTs which include sequences derived from the authentic 5' ends of their corresponding mRNAs. The term "corresponding mRNA" refers to the mRNA which was the template for the cDNA synthesis which produced the 5' EST. These sequences will be referred to hereinafter as "5' ESTs. " The present invention also includes purified, isolated or enriched nucleic acids comprising contigs assembled by determining a consensus sequences from a plurality of ESTs containing overlapping sequences. These contigs will be referred to herein as "consensus contigated ESTs. " As used herein, the term "purified" does not require absolute purity; rather, it is intended as a relative definition. Individual 5' EST clones isolated from a cDNA library have been conventionally purified to electrophoretic homogeneity. The sequences obtained from these clones could not be obtained directly either form the library or from total human DNA. The cDNA clones are not naturally occurring as such, but rather are obtained via manipulation of a partially purified naturally occurring substance (messenger RNA). The conversion of mRNA into a cDNA library involves the creation of a synthetic substance (cDNA) and pure individual cDNA clones can be isolated from the synthetic library by clonal selection. Thus, creating a cDNA library from messenger RNA and subsequently isolating individual clones from that library results in an approximately 10. sup. 4 -10. sup. 6 fold purification of the native message. Purification of starting material or natural material to at least one order of magnitude, preferably two or three orders, and more preferably four or five orders of magnitude is expressly contemplated. As used herein, the term "isolated" requires that the material be removed from its original environment (e. g. , the natural environment if it is naturally occurring). For example, a naturally-occurring polynucleotide present in a living animal is not isolated, but the same polynucleotide, separated from some or all of the coexisting materials in the natural system, is isolated
|
| Related patents |
|
|
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
The invention claimed is: 1. An isolated PC-LECTIN protein comprising the amino acid sequence of SEQ ID NO. 2. 2. The PC-LECTIN protein of claim 1 which is soluble. 3. ...
|
|
|
Antibodies for use in determining hemoglobin A.sub.1c
It is accordingly an object of the present invention to provide a comparatively simple, inexpensive, reliable test for determining the long-term blood sugar level of a ...
|
|
|
Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives
OF THE INVENTION A hapten of the invention is substantially optically pure, and is particularly useful in an immunoassay for cotinine, a metabolite of nicotine. As used ...
|
|
|
Immunogens and the use thereof for obtaining antibodies against HBA.sub.1C
What is claimed is: 1. Composition of matter consisting essentially of polyclonal antibodies which specifically bind to HbA.sub.1c and which have less than 5.0% cross ...
|
|
|
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
The present invention overcomes the above mentioned drawbacks and provides methods for treating drug abuse. Using therapeutic compositions, in particular hapten-carrier ...
|
|
|
Antibody against a 3-aminophenylboronic-glycated protein complex and its use in an immunoassay
OF THE INVENTION The present invention is directed to methods for developing and utilizing antibodies with preferred specificity for phenylboronic acid complexes of ...
|
|
|
Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
The invention claimed is: 1. An oral pharmaceutical formulation comprising phytosterols and isomers thereof, folic acid, cyanocobalamine, pyridoxine and dietetic ...
|
|
|
Stimulation of chemotaxis by chemotactic peptides
Accordingly, it is an object of this invention to provide a synthetic material having chemotactic properties towards cells such as fibroblasts and endothelial cells. It ...
|
|
|
Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic heart valve having an improved resistance to post-implantation ...
|
|
|
Diagnosis of Williams syndrome
OF THE INVENTION The present invention is directed to the determination that SVAS and Williams syndrome map to the elastin gene and that molecular variants of the ...
|
|
|